• Profile
Close

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: A systematic review and meta-regression analysis

The Lancet Infectious Diseases Evidence based | Mar 02, 2018

Gupta RK, et al. - Researchers here aimed at assessing the incidence of HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries. In low-income and middle-income countries (LMICs), pretreatment drug resistance seemed increasing at substantial rate. This was particularly evident in sub-Saharan Africa. In 2016, data from southern and eastern Africa and Latin America showed that the prevalence of pretreatment non-nucleoside reverse transcriptase inhibitors resistance was near WHO's 10% threshold for changing first-line antiretroviral therapy (ART). This highlights the necessity for routine national HIV drug-resistance surveillance and review of national policies for first-line ART regimen composition.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay